Claude Benedict
14Patents
6h-index
18Co-inventors
63Inventor score
Filing activity: Apr 6, 1993 → Mar 12, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7566701B2 | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics | Chemistry; Metallurgy | 25 | Expired |
| US7538211B2 | Aptamer therapeutics useful in the treatment of complement-related disorders | Chemistry; Metallurgy | 18 | Expired |
| US5426097A | Calreticulin: a novel antithrombotic agent | Emerging Cross-Sectional Technologies | 18 | Expired |
| US7579456B2 | Aptamer therapeutics useful in the treatment of complement-related disorders | Chemistry; Metallurgy | 16 | Expired |
| US5798372A | Method for preventing onset of restenosis after angioplasty employing a retinoid | Human Necessities | 11 | Expired |
| US7803931B2 | Aptamer therapeutics useful in the treatment of complement-related disorders | Chemistry; Metallurgy | 11 | Expired |
| US8236773B2 | Aptamer therapeutics useful in the treatment of complement-related disorders | Chemistry; Metallurgy | 6 | Active |
| US8436164B2 | Aptamer therapeutics useful in the treatment of complement-related disorders | Chemistry; Metallurgy | 4 | Active |
| US7589073B2 | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics | Chemistry; Metallurgy | 4 | Expired |
| US7998940B2 | Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics | Chemistry; Metallurgy | 3 | Active |
| US9617546B2 | Aptamer therapeutics useful in the treatment of complement-related disorders | Chemistry; Metallurgy | 1 | Active |
| US8946184B2 | Aptamer therapeutics useful in the treatment of complement-related disorders | Chemistry; Metallurgy | 0 | Active |
| US11913000B2 | Aptamer therapeutics useful in the treatment of complement-related disorders | Chemistry; Metallurgy | 0 | Active |
| US10947544B2 | Aptamer therapeutics useful in the treatment of complement-related disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.